Literature DB >> 31578084

Spatiotemporal Expression of 3-B-3(-) and 7-D-4 Chondroitin Sulfation, Tissue Remodeling, and Attempted Repair in an Ovine Model of Intervertebral Disc Degeneration.

Brooke Farrugia1, Susan M Smith2, Cindy C Shu2, James Melrose2,3,4.   

Abstract

OBJECTIVE: Examination of intervertebral disc (IVD) regeneration in an ovine annular lesion model. HYPOTHESIS: Sulfation motifs are important functional determinants in glycosaminoglycans (GAGs). Previous studies have correlated 3-B-3(-) and 7-D-4 chondroitin sulfate (CS) motifs in tissues undergoing morphogenetic transition in development. We hypothesize that these motifs may also be expressed in degenerate IVDs and may represent a reparative response.
DESIGN: Induction of disc degeneration by 5 mm or 6 × 20 mm lesions in the annulus fibrosus (AF) over 6 or 3 to 6 months postoperation (PO). Tissue sections were stained with toluidine blue-fast green, 3-B-3(-) and 7-D-4 CS-sulfation motifs were immunolocalized in 3-month PO 6 × 20 mm lesion IVDs. Sulfated glycosaminoglycan (GAG), 3-B-3(-), and 7-D-4 epitopes were quantitated by ELISIA (enzyme-linked immunosorbent inhibition assay) in extracts of AF (lesion site and contralateral half) and nucleus pulposus (NP) 0, 3, and 6 months PO.
RESULTS: Collagenous overgrowth of lesions occurred in the outer AF. Chondroid metaplasia in ~20% of the 6 × 20 mm affected discs resulted in integration of an outgrowth of NP tissue with the inner AF lamellae preventing propagation of the lesion. 3-B-3(-) and 7-D-4 CS sulfation motifs were immunolocalized in this chondroid tissue. ELISIA quantified CS sulfation motifs demonstrating an increase 3 to 6 months PO in the AF lesion and a reduction in sulfated GAG not evident in the contralateral AF.
CONCLUSIONS: (1) Outer annular lesions underwent spontaneous repair. (2) Chondroid metaplasia of the inner 6 × 20 mm defect prevented its propagation suggesting an apparent reparative response.

Entities:  

Keywords:  3-B-3(−); 7-D-4; annular repair; chondroitin sulfate motifs; tissue regeneration; tissue remodeling

Mesh:

Substances:

Year:  2019        PMID: 31578084      PMCID: PMC7097983          DOI: 10.1177/1947603519876354

Source DB:  PubMed          Journal:  Cartilage        ISSN: 1947-6035            Impact factor:   4.634


  109 in total

1.  1990 Volvo Award in experimental studies. Anulus tears and intervertebral disc degeneration. An experimental study using an animal model.

Authors:  O L Osti; B Vernon-Roberts; R D Fraser
Journal:  Spine (Phila Pa 1976)       Date:  1990-08       Impact factor: 3.468

2.  The mechanical effects of intervertebral disc lesions.

Authors:  Rosemary E Thompson; Mark J Pearcy; Timothy M Barker
Journal:  Clin Biomech (Bristol, Avon)       Date:  2004-06       Impact factor: 2.063

3.  Spinal manipulation force and duration affect vertebral movement and neuromuscular responses.

Authors:  Christopher J Colloca; Tony S Keller; Deed E Harrison; Robert J Moore; Robert Gunzburg; Donald D Harrison
Journal:  Clin Biomech (Bristol, Avon)       Date:  2005-12-27       Impact factor: 2.063

4.  Remodeling of vertebral bone after outer anular injury in sheep.

Authors:  R J Moore; B Vernon-Roberts; O L Osti; R D Fraser
Journal:  Spine (Phila Pa 1976)       Date:  1996-04-15       Impact factor: 3.468

5.  Multifidus Muscle Changes After Back Injury Are Characterized by Structural Remodeling of Muscle, Adipose and Connective Tissue, but Not Muscle Atrophy: Molecular and Morphological Evidence.

Authors:  Paul W Hodges; Gregory James; Linda Blomster; Leanne Hall; Annina Schmid; Cindy Shu; Chris Little; James Melrose
Journal:  Spine (Phila Pa 1976)       Date:  2015-07-15       Impact factor: 3.468

Review 6.  Small leucine-rich proteoglycans (SLRPs): characteristics and function in the intervertebral disc.

Authors:  Lili Chen; Jingwen Liao; Eric Klineberg; Victor Yl Leung; Shishu Huang
Journal:  J Tissue Eng Regen Med       Date:  2015-09-14       Impact factor: 3.963

7.  Transforming growth factor-β1 (TGF-β1)-stimulated fibroblast to myofibroblast differentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafts.

Authors:  Adam C Midgley; Mathew Rogers; Maurice B Hallett; Aled Clayton; Timothy Bowen; Aled O Phillips; Robert Steadman
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

8.  Effects of disc degeneration on neurophysiological responses during dorsoventral mechanical excitation of the ovine lumbar spine.

Authors:  Christopher J Colloca; Tony S Keller; Robert J Moore; Robert Gunzburg; Deed E Harrison
Journal:  J Electromyogr Kinesiol       Date:  2007-04-30       Impact factor: 2.368

9.  Immunochemical and biochemical comparisons between embryonic chick bone marrow and epiphyseal cartilage chondroitin/dermatan sulphate proteoglycans.

Authors:  J M Sorrell; F Mahmoodian; B Caterson
Journal:  J Cell Sci       Date:  1988-09       Impact factor: 5.285

Review 10.  Concise Review: Stem/Progenitor Cell Proteoglycans Decorated with 7-D-4, 4-C-3, and 3-B-3(-) Chondroitin Sulfate Motifs Are Morphogenetic Markers of Tissue Development.

Authors:  Anthony J Hayes; Susan M Smith; Bruce Caterson; James Melrose
Journal:  Stem Cells       Date:  2018-07-31       Impact factor: 6.277

View more
  2 in total

1.  Extracellular Matrix From Decellularized Wharton's Jelly Improves the Behavior of Cells From Degenerated Intervertebral Disc.

Authors:  Letizia Penolazzi; Michela Pozzobon; Leticia Scussel Bergamin; Stefania D'Agostino; Riccardo Francescato; Gloria Bonaccorsi; Pasquale De Bonis; Michele Cavallo; Elisabetta Lambertini; Roberta Piva
Journal:  Front Bioeng Biotechnol       Date:  2020-03-27

2.  A comprehensive tool box for large animal studies of intervertebral disc degeneration.

Authors:  Naomi N Lee; Elias Salzer; Frances C Bach; Andres F Bonilla; James L Cook; Zulma Gazit; Sibylle Grad; Keita Ito; Lachlan J Smith; Andrea Vernengo; Hans-Joachim Wilke; Julie B Engiles; Marianna A Tryfonidou
Journal:  JOR Spine       Date:  2021-06-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.